4Living Biotech
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb) (NCT05411575) | 4Living Biotech | 2022-07-19 |
Track 4Living Biotech automatically
Every clearance here is in the API, with alerts when new ones post.